PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

Regulation of Tip60‐dependent p53 acetylation in cell fate decision

Wang, P., Bao, H., Zhang, X., Liu, F., & Wang, W. (2018) · FEBS Letters · doi:10.1002/1873-3468.13287 · Cited by 21

Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches

Nguyen, H.-M., Paulishak, W., Oladejo, M., & Wood, L. M. (2022) · Breast Cancer · doi:10.1007/s12282-022-01415-4 · Cited by 24

Regulation of p53-dependent transcription

Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20

Ultraviolet B ‐induced LGI 3 secretion protects human keratinocytes

Lee, S. H., Jeong, Y., Kim, S., Jeong, H., Park, K., Baek, K. J., Kwon, N. S., Yun, H., & Kim, D. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01550.x · Cited by 19

Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision

Sun, C., Zhang, X., & Wang, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194768 · Cited by 19

Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer

Vázquez‐Ulloa, E., Lizano, M., Avilés‐Salas, A., Alfaro‐Moreno, E., & Contreras‐Paredes, A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.017 · Cited by 19

Novel indole α-methylene-γ-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases

Ding, H., Zhang, C., Wu, X., Yang, C., Zhang, X., Ding, J., & Xie, Y. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.050 · Cited by 19

Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells

Khatun, A., Shimozawa, M., Kito, H., Kawaguchi, M., Fujimoto, M., Ri, M., Kajikuri, J., Niwa, S., Fujii, M., & Ohya, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00312 · Cited by 19

Sprouty 2 Regulates DNA Damage-induced Apoptosis in Ras-transformed Human Fibroblasts

Lito, P., Mets, B. D., Appledorn, D. M., Maher, V. M., & McCormick, J. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808045200 · Cited by 19

Studies on modulation of the activity of tumor suppressor protein p53

Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 19

EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis

Liu, X., Gao, X. W., Yang, Y., Yang, D., Guo, Q., Li, L., Liu, S., Cong, W., Lu, S., Hou, L., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01967-0 · Cited by 18

Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts

Urbanek, K., Lesiak, M., Krakowian, D., Koryciak-Komarska, H., Likus, W., Czekaj, P., Kusz, D. J., & Sieroń, A. L. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.60 · Cited by 18

The AP-2 transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene

Choi, H., Chung, T., Kim, S. J., Cho, S. Y., Lee, Y., Lee, Y., Ko, J. H., & Kim, C. (2008) · Glycobiology · doi:10.1093/glycob/cwn016 · Cited by 18

Interplay between Mdm2 and HIPK2 in the DNA damage response

Zhang, X., Liu, F., & Wang, W. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0319 · Cited by 19

Pten signaling in gliomas

Knobbe-Thomsen, C. B., Merlo, A. U., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1215/s1522851702000029 · Cited by 18

Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor

Tsai, K.-Y., Lai, Z., Chang, S., & Chuang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168784 · Cited by 18

p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect

Abukwaik, R., Vera-Sigüenza, E., Tennant, D. A., & Spill, F. (2024) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01346-5 · Cited by 19

Functional analysis of GNG2 in human malignant melanoma cells

Yajima, I., Kumasaka, M. Y., Tamura, H., Ohgami, N., & Kato, M. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.09.009 · Cited by 17

PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress

Ghorbani, A., Zand, H., Jeddi‐Tehrani, M., Koohdani, F., Shidfar, F., & Keshavarz, S. A. (2015) · Journal of Natural Medicines · doi:10.1007/s11418-015-0915-7 · Cited by 17

VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN

Li, Y., Weng, Y., Zhong, L., Chong, H., Chen, S., Sun, Y., Li, W., & Shi, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.5969 · Cited by 17

Prognostic Role of PTEN Gene Expression and Length of Survival of Breast Cancer Patients in the North East of Iran

Golmohammadi, R., Rakhshani, M. H., Moslem, A., & Pejhan, A. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.s3.305 · Cited by 17

Profiling of genes expressed by PTEN haploinsufficient neural precursor cells

Li, L., He, F., Litofsky, N. S., Recht, L. D., & Ross, A. H. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.08.010 · Cited by 17

Human Glioblastoma U87MG Cells Transduced with a Dominant Negative p53 (TP53) Adenovirus Construct Undergo Radiation-Induced Mitotic Catastrophe

Ianzini, F., Domann, F. E., Kosmacek, E. A., Phillips, S. L., & Mackey, M. A. (2007) · Radiation Research · doi:10.1667/0033-7587(2007)168[183:hguctw]2.0.co;2 · Cited by 17

Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms

Kato, T., Murata, D., Anders, R. A., Sesaki, H., & Iijima, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.093 · Cited by 16

Multiple signaling pathways are involved in the regulation of IGF-I receptor inhibition of PTEN-enhanced apoptosis

Wu, Y., Karas, M., Dupont, J., Zhao, H., Toyoshima, Y., & Roith, D. L. (2003) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2003.08.003 · Cited by 16

Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner

Wamsley, J. J., Gary, C., Biktasova, A., Hajek, M., Bellinger, G., Virk, R. K., Issaeva, N., & Yarbrough, W. G. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.12 · Cited by 15

A highly integrated precision nanomedicine strategy to target esophageal squamous cell cancer molecularly and physically

Wang, X.-S., Ding, X.-Z., Li, X.-C., He, Y., Kong, D.-J., Zhang, L., Hu, X.-C., Yang, J.-Q., Zhao, M.-Q., Gao, S.-G., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.06.008 · Cited by 16

Cell cycle effects of topotecan alone and in combination with irradiation

Ohneseit, P., Prager, D., Kehlbach, R., & Rodemann, H. P. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.03.025 · Cited by 15

Genetic alterations of human brain tumors as molecular prognostic factors

Shiraishi, T., & Tabuchi, K. (2003) · Neuropathology · doi:10.1046/j.1440-1789.2003.00477.x · Cited by 15

Synthetic RNA Therapeutics in Cancer

Han, Y., Shin, S.-H., Lim, C. G., Heo, Y. H., Choi, I. Y., & Kim, H. H. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001587 · Cited by 14

Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells

Amos, S., Redpath, G. T., Polar, G. A., McPheson, R., Schiff, D., & Hussaini, I. M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401783 · Cited by 14

Roles of PI3-K/Akt pathways in nanoparticle realgar powders-induced apoptosis in U937 cells

Xi, R., Huang, J. M., Li, D., Wang, X., & Li-jun, W. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00759.x · Cited by 14

HER-2/Neu signaling and therapeutic approaches in breast cancer

Zhou, B. P., Li, Y., & Hung, M. (2002) · Breast Disease · doi:10.3233/bd-2002-15103 · Cited by 14

Ectodomain-Specific E-Cadherin Antibody Suppresses Skin SCC Growth and Reduces Tumor Grade: A Multitargeted Therapy Modulating RTKs and the PTEN–p53–MDM2 Axis

Brouxhon, S. M., Kyrkanides, S., Raja, V., Silberfeld, A., Teng, X., Trochesset, D. A., Cohen, J., & Ma, L. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0971 · Cited by 13

Overview of the biochemical and genetic processes in malignant mesothelioma

de Assis, L. V. M., & Isoldi, M. C. (2014) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132014000400012 · Cited by 12

Mechanism of the inhibition of leukemia cell growth and induction of apoptosis through the activation of ATR and PTEN by the topoisomerase inhibitor 3EZ, 20Ac-ingenol

Miyata, S., Fukuda, Y., Tojima, H., Matsuzaki, K., Kitanaka, S., & Sawada, H. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.06.006 · Cited by 13

Evaluation of Arginine Deiminase Treatment in Melanoma Xenografts Using 18F-FLT PET

Stelter, L., Fuchs, S., Jungbluth, A. A., Ritter, G., Longo, V. A., ZANZONICO, P. B., Raschzok, N., Sauer, I. M., Bomalaski, J. S., & Larson, S. M. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0655-6 · Cited by 13

Role of p53 family in birth defects: Lessons from zebrafish

Danilova, N., Sakamoto, K. M., & Lin, S. (2008) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20129 · Cited by 13

MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism

Ren, G., Yang, E. J., Tao, S., Mou, P. K., Pu, Y., Chen, L., & Shim, J. S. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82566 · Cited by 12

USP13 regulates cell senescence through mediating MDM2 stability

He, J., Baoyinna, B., Taleb, S. J., Zhao, J., & Zhao, Y. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122044 · Cited by 12

Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells

Zhang, M., Fang, X., Liu, H., Guo, R., Wu, X., Li, B., Zhu, F., Ling, Y., Griffith, B. N., Wang, S., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.035 · Cited by 12

8q24 Amplification in Transitional Cell Carcinoma of Bladder

Visapää, H., Seligson, D. B., Eeva, M., Gaber, F., Rao, J., Belldegrun, A. S., & Palotie, A. V. (2003) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200303000-00006 · Cited by 12

UV Exposure, Genetic Targets in Melanocytic Tumors and Transgenic Mouse Models¶

de Gruijl, F. R., van Kranen, H. J., & van Schanke, A. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-09-26-ir-328.1 · Cited by 12

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

Serebriiskii, I. G., Pavlov, V. A., Andrianov, G. V., Litwin, S., Basickes, S., Newberg, J. Y., Frampton, G. M., Meyer, J. E., & Golemis, E. A. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00384-7 · Cited by 11

Inhibition of Malignant Glioma Cell Growth by a Survivin Mutant Retrovirus

Temme, A., Herzig, E., Weigle, B., Morgenroth, A., Schmitz, M., Kießling, A., Rieger, M. A., Schackert, H. K., & Rieber, E. P. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.209 · Cited by 11

The clinical development of p53-reactivating drugs in sarcomas – charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins

Biswas, S., Killick, E., Jochemsen, A. G., & Lunec, J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.892924 · Cited by 11

Mathematical modeling to distinguish cell cycle arrest and cell killing in chemotherapeutic concentration response curves

Hamed, S. S., & Roth, C. M. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9199-z · Cited by 10

Low expression of phosphatase and tensin homolog in clear-cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway

Chen, J., Zhu, H., Zhang, Y., Cui, M., Han, L., JIA, Z.-H., Wang, L., Teng, H., & Miao, L. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3740 · Cited by 10

Gα12/13 Basally Regulates p53 through Mdm4 Expression

Kim, M.-S., Lee, S. M., Kim, W., Ki, S. H., Moon, A., Lee, C. H., & Kim, S. G. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0395 · Cited by 10

Protective Effects of Selenomethionine Against Ionizing Radiation Under the Modulation of p53 Tumor Suppressor

Jeong, S. W., Jung, H. J., Rahman, M. M., Hwang, J. N., & Seo, Y. R. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2007.0719 · Cited by 9

Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog

Mujoo, K., Watanabe, M., Khokhar, A. R., & Siddik, Z. H. (2004) · The Prostate · doi:10.1002/pros.20114 · Cited by 9

Puzzling phenomenon: adult-onset cancer predisposition and pediatric cancer

Kuhlen, M., Hofmann, T. G., & Golas, M. M. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.02.011 · Cited by 8

The effect of endurance training with and without vitamin E on expression of p53 and PTEN tumor suppressing genes in prostate glands of male rats

Dashtiyan, A. A., Sepehrimanesh, M., Tanideh, N., & Afzalpour, M. E. (2017) · Biochimie Open · doi:10.1016/j.biopen.2017.03.005 · Cited by 8

p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy

Haaland, I., Hjelle, S. M., Reikvam, H., Sulen, A., Ryningen, A., McCormack, E., Bruserud, Ø., & Gjertsen, B. T. (2021) · Cells · doi:10.3390/cells10040833 · Cited by 9

GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway

Chen, R., Zhao, M., An, Y., Liu, D., & Tang, Q. (2023) · BMC Cancer · doi:10.1186/s12885-023-11107-7 · Cited by 8

The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status

Köstler, W. J., Brodowicz, T., Hudelist, G., Rudas, M., Horvat, R., Steger, G. G., Singer, C. F., Attems, J., Rabitsch, W., Fakhrai, N., et al. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0670-3 · Cited by 8

Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-β Pathways in Prostate Cancer

Assinder, S. J., Dong, Q., Mangs, H., & Richardson, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.053066 · Cited by 8

PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women

Gbelcová, H., Gergely, L., Šišovský, V., Straka, Ľ., Böhmer, D., Pastorakova, A., Sušienková, K., Repiská, V., Korbeľ, M., Danihel, Ľ., et al. (2022) · Physiological Research · doi:10.33549/physiolres.935030 · Cited by 7

Interplay of p53 and XIAP protein dynamics orchestrates cell fate in response to chemotherapy

Abukwaik, R., Vera-Sigüenza, E., Tennant, D. A., & Spill, F. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111562 · Cited by 7

Luminal A breast cancer resistance mechanisms and emerging treatments

Anderson, D. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00010-3 · Cited by 10

PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells

Ghobashi, A. H., Kimani, J. W., Ladaika, C. A., & O’Hagan, H. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313769 · Cited by 6

Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer

Grazia, G., Conti, C., Nucera, S., Stella, S., Massimino, M., Giuliano, M., Schettini, F., Vigneri, P. G., & Martorana, F. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104834 · Cited by 6

MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53

Zhang, X., Yamamoto, Y., Wang, X., Sato, M., Imanishi, M., Sugaya, A., Hirose, M., Endo, S., Moriwaki, T., Yamato, K., et al. (2021) · Anticancer Research · doi:10.21873/anticanres.14906 · Cited by 6

The PTEN/PI3 Kinase Pathway in Human Glioma

Stokoe, D., & Furnari, F. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_15 · Cited by 6

New Insights into Prostate Cancer Biology

Balakumaran, B. S., & Febbo, P. G. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.06.005 · Cited by 6

The PI3 Kinase/Akt Pathway as a Therapeutic Target in Multiple Myeloma

Harvey, R. D., Silberman, J., & Lonial, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-564-0_20 · Cited by 6

The Role and Mechanism of Innate Immune Regulation in Overcoming Oxaliplatin Resistance and Enhancing Anti-Tumor Efficacy in Colorectal Cancer

Wang, X., Xi, M., Lu, X., & Tan, X. (2025) · Pharmaceuticals · doi:10.3390/ph18030317 · Cited by 5

Abnormalities of cell structures in tumors: apoptosis in tumors

Cheung, H. H., Arora, V. A., & Korneluk, R. G. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7378-4_9 · Cited by 5

Therapeutic considerations for Mdm2: not just a one trick pony

Lehman, J. A., Eitel, J. A., Batuello, C. N., & Mayo, L. D. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.11.1309 · Cited by 6

PTEN in Prostate Cancer

Ruscetti, M. A., & Wu, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_4 · Cited by 6

Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

Kitagishi, Y., Matsuda, S., Minami, A., Ono, Y., Nakanishi, A., & Ogura, Y. (2014) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-1-101 · Cited by 4

Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers

Jugel, W., Tietze, S., Daeg, J., Appelhans, D., Broghammer, F., Aigner, A. M., Karimov, M., Schackert, G., & Temme, A. (2022) · Cancers · doi:10.3390/cancers14081925 · Cited by 4

The Power of Synergism: A Novel Drug Combination for Improved Therapy of Glioblastoma

Maravajjala, K. S., Kothekar, A., & Roy, A. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300315 · Cited by 4

Working title: Molecular involvement of p53‐MDM2 interactome in gastrointestinal cancers

Poornachandra, Y., Bhamidipati, P., Syed, R., & Amanchy, R. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4075 · Cited by 5

Diagnostic and Prognostic Values of PTEN Expression in Functional and Pathological Endometrial Biopsies

Allithy, A. N. A., Ammar, I. M. M., & Mohammed, M. H. (2022) · Asian Pacific Journal of Cancer Biology · doi:10.31557/apjcb.2022.7.1.21-27 · Cited by 4

Induction of the Mdm2 gene and protein by kinase signaling pathways is repressed by the pVHL tumor suppressor

Mabry, A., Singh, A., Mulrooney, B., Gorman, J., Thielbar, A. R., Wolf, E. R., & Mayo, L. D. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400935121 · Cited by 4

β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells.

Artene, Ş.-A., Folcuţi, C., & Dricu, A. (2017) · Europe PMC (PubMed Central) · doi:10.12865/chsj.43.02.02 · Cited by 4

Pharmacogenomics of the p53 tumor suppressor and its role in cancer chemoresistance

Liu, S., Bishop, W. R., Dasmahapatra, B., & Wang, Y. (2004) · Drug Development Research · doi:10.1002/ddr.10362 · Cited by 4

Regulation of PEST-containing nuclear proteins in cancer cells: implications for cancer biology and therapy

Jiang, K., Zhu, Y.-H., Jiang, Z., Liu, Y., Hussain, W., Luo, H.-Y., Sun, W.-H., Ji, X.-Y., & Li, D. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1548886 · Cited by 4

Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis

Chen, J. Y., Yang, H., Wen, J., Luo, K. J., Liu, Q., Lei, J., Zhen, Y., & Fu, J. (2015) · Diseases of the Esophagus · doi:10.1111/dote.12361 · Cited by 3

Lentiviral vector-mediated gene transfer combined with cisplatin enhances tumor suppression in human bladder cancer cell lines

Ichikawa, M., Matsunaga, W., Ishikawa, T., & Gotoh, A. (2019) · Personalized Medicine Universe · doi:10.1016/j.pmu.2019.06.002 · Cited by 3

Associating Graphene Oxide Derivatives to Treat Non-Muscle Invasive Bladder Cancer (NMIBC)

(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac121.196210 · Cited by 3

3EZ, 20Ac-ingenol induces cell-specific apoptosis in cyclin D1 over-expression through the activation of ATR and downregulation of p-Akt

Miyata, S., Wang, L., & Kitanaka, S. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.08.007 · Cited by 3

Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report

Wang, L., Dong, F., Su, J. S., Du, G., Shao, Y. W., Liu, Y., He, X., Bao, L., Wang, W., Guo, X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01048 · Cited by 3

Prognostic Importance of PTEN, p53, and MDM2 Expressions in Endometrioid and Serous-Type Endometrial Carcinomas

Acat, S., Çelik, Z. E., GÜLER, A. H., & Çelık, Ç. (2024) · Medical Records · doi:10.37990/medr.1486449 · Cited by 2

Conservative Medroxyprogesterone Acetate Therapy in Early Stage of Endometrial Carcinoma Associated with Phosphatase and Tensin Homolog Expression

Niwa, K., Mori, M., Miyazaki, T., Tanaka, T., & Morishige, K. (2016) · Open Journal of Pathology · doi:10.4236/ojpathology.2017.71001 · Cited by 2

Divergent PTEN–p53 interaction upon DNA damage in a human thyroid organoid model with germline PTEN mutations

Venegas, J. A., Onur, O. E., Kang, S. C., Hitomi, M., & Eng, C. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0216 · Cited by 5

Deep learning prioritizes cancer mutations that alter protein nucleocytoplasmic shuttling to drive tumorigenesis

Zheng, Y., Yu, K., Lin, J., Liang, Z., Zhang, Q., Li, J., Wu, Q., He, C., Mei, L., Zhao, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57858-8 · Cited by 2

Crosstalk Between Plk1 and PTEN in Mitosis Affects Chromosomal Stability

Li, W., Wang, X., Liu, J., Liu, B., & Hao, Y. (2025) · DNA and Cell Biology · doi:10.1089/dna.2024.0246 · Cited by 2

Inhibition of transfected PTEN on human colon cancer

Shoushui, X. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i24.3670 · Cited by 2

Expression of P53, PTEN and S100A4 in invasive ductal breast cancer and the clinical significance

Zhang, G., Zhong, L., Xiao-meng, L., Jun-hua, Z., Yong, C., & Zhao, X. (2015) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v6i6.12599 · Cited by 2

Use of Insulin to Increase Epiblast Cell Number: Towards a New Approach for Improving ESC Isolation from Human Embryos

Campbell, J. M., Lane, M., Vassiliev, I. M., & Nottle, M. B. (2013) · BioMed Research International · doi:10.1155/2013/150901 · Cited by 2

Role Of Nuclear Plc And PI3K Signaling In The Development Of Cancer

Faenza, I., Ramazzotti, G., Bavelloni, A., Bregoli, L., Fiume, R., Gaboardi, G. C., Manzoli, L., Matteucci, A., Martelli, A. M., & Cocco, L. (2007) · Future Lipidology · doi:10.2217/17460875.2.3.303 · Cited by 2

Hypothesis

Azimi, A., & Azimi, A. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000476 · Cited by 2

Introduction to Genes, Oncogenes, and Anti-oncogenes

Das, U. N. (2020) · Springer eBooks · doi:10.1007/978-1-0716-0741-1_1 · Cited by 2

The p53-Mdm2 Loop: A Critical Juncture of Stress Response

Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 2

Uterine cervical neoplasia : aspects of biology and pathology

Bertelsen, B. I. (2007) · NORA - Norwegian Open Research Archives · Cited by 2

Relationship between Scientific Reasoning and Scientific-Mathematical Content Knowledge in International General Certificate of Secondary Education and International Baccalaureate Diploma Programs

AKIŞ, D., & Metlí, A. (2022) · Sakarya Üniversitesi Eğitim Fakültesi Dergisi · doi:10.53629/sakaefd.736800 · Cited by 1

Targeting the p53 tumor suppressor gene function in glioblastomas using small chemical molecules

Magrini, R., Bakker, A. C., Gaviraghi, G., & Terstappen, G. C. (2006) · Drug Development Research · doi:10.1002/ddr.20151 · Cited by 1

Genomic Evaluation and Management of Prostate Cancer

Febbo, P. G., & Kantoff, P. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00037-4 · Cited by 1

The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network

Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 419

PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.

Zhou, M., Gu, L., Findley, H. W., Jiang, R., & Woods, W. G. (2003) · PubMed · Cited by 120

Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

Kitagishi, Y., Matsuda, S., Minami, A., Ono, Y., Nakanishi, A., & Ogura, Y. (2014) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-1-101 · Cited by 4

PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations

Li, Y., Guessous, F., Kwon, S., Kumar, M., Ibidapo, O., Fuller, L., Johnson, E., Lal, B., Hussaini, I., Bao, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1963 · Cited by 95

PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

Freeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N. L., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00021-7 · Cited by 512